You are here

  • Home
  • Archive
  • Volume 79, Issue 6
  • Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries

Article metrics

Article menu
Download PDFPDF
Letter
Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries

 

Online download statistics by month:

Online download statistics by month: February 2020 to March 2024

AbstractFullPdf
Feb 202023673
Mar 2020201413472
Apr 20203462421
May 202015493219
Jun 202014442724
Jul 20201393023
Aug 20204742
Sep 202097105
Oct 20203743
Nov 20205283
Dec 20205874
Jan 20216343
Feb 20215643
Mar 20216974
Apr 20216943
May 20211911
Jun 202115132
Jul 2021110
Aug 2021642
Sep 2021442
Oct 20216810
Nov 202110632
Dec 20214521
Jan 20228474
Feb 20228721
Mar 20229130
Apr 20228751
May 20229810
Jun 20225731
Jul 20226911
Aug 202210920
Sep 20229231
Oct 202213241
Nov 20227431
Dec 20227210
Jan 202348127
Feb 202310730
Mar 20232020
Apr 20231620
May 202333122
Jun 2023620
Jul 20233800
Aug 20231643
Sep 20231610
Oct 20233820
Nov 20231941
Dec 20234910
Jan 20243310
Feb 20244412
Mar 20242221
Total8097419229